1 Tweedy Browne Ligand Pharmaceuticals Trades

Tweedy Browne acquired 3.14k Ligand Pharmaceuticals shares worth $527k. That's 0.05% of their equity portfolio (51st largest holding). The stake costed the investor $336k, netting the investor a gain of 57% so far.